tiprankstipranks
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
US Market
STRO
Sutro Biopharma
RESEARCH TOOLSreports
Want to see STRO full AI Analyst Report?

Sutro Biopharma (STRO) Stock News & Sentiment

740 Followers
Maldonado Reiterates Buy on Sutro, Sees STRO-004 Data as Proof-of-Concept and Keeps $50 Price Target Unchanged
Premium
Ratings
Maldonado Reiterates Buy on Sutro, Sees STRO-004 Data as Proof-of-Concept and Keeps $50 Price Target Unchanged
28d ago
STRO
Sutro Biopharma: Encouraging STRO-004 Early Data and Solid Execution Support Unchanged $54 Price Target and Buy Rating
Premium
Ratings
Sutro Biopharma: Encouraging STRO-004 Early Data and Solid Execution Support Unchanged $54 Price Target and Buy Rating
28d ago
STRO
Sutro Biopharma Q2 Results Highlight Advancing ADC Pipeline
Premium
Company Announcements
Sutro Biopharma Q2 Results Highlight Advancing ADC Pipeline
28d ago
8K
STRO
Sutro Biopharma (STRO) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Sutro Biopharma (STRO) Q2 Earnings Cheat Sheet
1M ago
STRO
Sutro Biopharma Shareholders Back Board, Pay and Auditor
Premium
Company Announcements
Sutro Biopharma Shareholders Back Board, Pay and Auditor
3M ago
8K
STRO
Analyst Reaffirms Buy on Sutro Biopharma as Advancing ADC Platform and Upcoming STRO-004 Data Drive Upside Optionality
Premium
Ratings
Analyst Reaffirms Buy on Sutro Biopharma as Advancing ADC Platform and Upcoming STRO-004 Data Drive Upside Optionality
3M ago
STRO
Analyst Reiterates Buy on Sutro Biopharma, Maintains $54 Price Target on Differentiated ADC Platform and Pipeline Progress
Premium
Ratings
Analyst Reiterates Buy on Sutro Biopharma, Maintains $54 Price Target on Differentiated ADC Platform and Pipeline Progress
4M ago
STRO
More STRO News >

STRO News on the Web

Velan Capital Investment Management LP Expands Edesa Biotech Inc (EDSA) Stake
GuruFocus News
Neutral
Analysts Conflicted on These Healthcare Names: Definium Therapeutics (DFTX), Ionis Pharmaceuticals (IONS) and Sutro Biopharma (STRO)
TipRanks News
Neutral
Maldonado Reiterates Buy on Sutro, Sees STRO-004 Data as Proof-of-Concept and Keeps $50 Price Target Unchanged
TipRanks News
Bullish
Sutro Announces Encouraging Early Clinical Activity From STRO-004 Phase 1 Study; Stock Down
rttnews
Neutral
Barclays Sticks to Its Buy Rating for Sutro Biopharma (STRO)
TipRanks News
Bullish
Sutro Biopharma Shareholders Back Board, Pay and Auditor
TipRanks News
Neutral
Sutro Biopharma Inc Annual Shareholders Meeting Transcript
GuruFocus News
Neutral
Barclays Initiates a Buy Rating on Sutro Biopharma (STRO)
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average4.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is STRO’s Media Buzz Sentiment?
Currently, no data Available
What is STRO’s weekly average amount of articles?
In an average week, 4.25 articles about STRO are published.
    What is STRO’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    GHGuardant Health
    ABBVAbbVie
    BIIBBiogen
    BEAMBeam Therapeutics
    QUREuniQure
    Showing the stocks with the most bullish news sentiment over the past week